COMP <GO>

CLX vs V // EV/EBITDA & P/E VALUATION

Clorox Company (The) (NYSE) VS. Visa Inc. (NYSE) • 15-METRIC TALLY: CLX 7 — V 8

▲ EV/EBITDA & P/E VALUATION LEADER: CLX

LAST: $88.00 (-0.76%) • MKT CAP: $10.72B

valuation

10.9x

LAST: $413.59 (+0.74%) • MKT CAP: $733.53B

valuation

28.9x

15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CLX VS. V) EMERALD CELL = QUANTITATIVE EDGE

INSTITUTIONAL METRIC	CLX	V	SPREAD (A - B)	ADVANTAGE	DEDICATED URL
Gross Profit Margin	45.20%	41.00%	+4.20	CLX	/gross-margins <GO>
Return on Invested Capital (ROIC)	37.20%	32.30%	+4.90	CLX	/roic <GO>
EV/EBITDA & P/E Valuation ACTIVE	10.9x	28.9x	-18.00	CLX	/valuation <GO>
Free Cash Flow Yield	7.10%	2.90%	+4.20	CLX	/fcf-yield <GO>
Operating Margin	14.20%	60.00%	-45.80	V	/operating-margins <GO>
Net Profit Margin	11.60%	50.10%	-38.50	V	/net-margins <GO>
Revenue Growth (YoY)	0.20%	11.30%	-11.10	V	/revenue-growth <GO>
Dividend Yield & FCF Payout Safety	5.61%	0.63%	+4.98	CLX	/dividend-safety <GO>
Altman Z-Score & Debt/Equity	2.93	9.09	-6.16	V	/balance-sheet <GO>
Piotroski F-Score Quality	7/9	9/9	-2.00	V	/piotroski-score <GO>
Options Implied Move & Put/Call Skew	6.70%	7.10%	-0.40	CLX	/options-implied-move <GO>
RSI-14 & 200D SMA Momentum	53.8	69.4	-15.60	V	/rsi-technicals <GO>
10Y Yield & FRED Macro Beta	0.93	1.06	-0.13	V	/macro-sensitivity <GO>
Forward P/E Multiple	12.1x	34.0x	-21.90	CLX	/forward-pe <GO>
Enterprise Scale & Market Cap	$10.72B	$733.53B	-$722.81B	V	/market-cap <GO>

5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY

FISCAL YEAR	CLX REV	V REV	CLX GROSS %	V GROSS %	CLX FCF	V FCF
FY 2025	$7.10B	$40.00B	45.2%	44.0%	$761.0M	$21.26B
FY 2024	$7.09B	$35.93B	43.0%	44.0%	$483.0M	$18.33B
FY 2023	$7.39B	$32.65B	44.0%	44.0%	$825.5M	$19.29B

FRED MACRO REGIME CORRELATION COMPARISON PEARSON r

CLX // BETA 0.93

V // BETA 1.06